Rockwell Automation Launches PharmaSuite 12.00 to Accelerate Secure, Scalable Deployments

Latest MES release helps pharmaceutical and biopharmaceutical manufacturers simplify system management, improve flexibility and speed time-to-value

Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced the launch of FactoryTalk® PharmaSuite® 12.00. The latest release of its manufacturing execution system (MES) is designed to support the unique needs of regulated pharmaceutical and biopharmaceutical manufacturing environments, helping companies simplify system management, accelerate deployments and scale production more efficiently.


As the industry seeks to move faster while ensuring compliance, BioPhorum has noted that current MES solutions are often perceived as expensive, slow to implement and lacking flexibility required for modern operations. PharmaSuite 12.00 directly addresses these pain points, providing a simplified, configurable and future-ready platform for regulated life sciences production.

The latest release introduces a modular architecture and new cloud-ready capabilities, providing manufacturers with increased agility to help meet rapidly evolving production demands. It also features enhanced cybersecurity to support the stringent compliance and data integrity standards required in regulated life sciences environments.

"PharmaSuite 12.00 represents a major step forward in helping life sciences manufacturers embrace modular, digital production while maintaining the highest standards of performance, availability, compliance and security," said Martin Petrick, business manager, MES at Rockwell Automation. "With the flexibility to deploy in the cloud, on-premises or in hybrid models, manufacturers can scale operations faster, simplify global rollouts and reduce the time and cost validation."

Key new features in FactoryTalk PharmaSuite 12.00 include:
- Cloud-Based Deployment: Now runs in Kubernetes using Linux containers, making setup and maintenance faster and more reliable
- New Setup Tool (MICKA): Automates installation and validation steps to reduce manual effort in regulated environments
- Modular Design: Containerized components make it easy to scale across sites and standardize system deployments
- Built-in Monitoring: Centralized tools help detect issues early and speed up troubleshooting
- Strong Cybersecurity: Built using certified secure development practices to meet industry standards
- Easier Upgrades: A new upgrade engine helps keep systems current with the latest features and security updates

FactoryTalk PharmaSuite 12.00 builds on more than 15 years of continuous development and industry expertise. With this release, Rockwell continues to provide pharmaceutical and biopharmaceutical manufacturers with a modern, regulatory-compliant MES platform that supports scalable production, rapid deployment and digital transformation goals.

Featured Product

T.J. Davies' Retention Knobs

T.J. Davies' Retention Knobs

Our retention knobs are manufactured above international standards or to machine builder specifications. Retention knobs are manufactured utilizing AMS-6274/AISI-8620 alloy steel drawn in the United States. Threads are single-pointed on our lathes while manufacturing all other retention knob features to ensure high concentricity. Our process ensures that our threads are balanced (lead in/lead out at 180 degrees.) Each retention knob is carburized (hardened) to 58-62HRC, and case depth is .020-.030. Core hardness 40HRC. Each retention knob is coated utilizing a hot black oxide coating to military specifications. Our retention knobs are 100% covered in black oxide to prevent rust. All retention knob surfaces (not just mating surfaces) have a precision finish of 32 RMA micro or better: ISO grade 6N. Each retention knob is magnetic particle tested and tested at 2.5 times the pulling force of the drawbar. Certifications are maintained for each step in the manufacturing process for traceability.